# üíä Medication Analysis Report
**Generated:** 2025-12-28 13:43:22
**Analysis System:** MedicationAnalyzer (Comprehensive Drug Analysis)

---

## üìã Medication Overview
**Name:** Paracetamol
**Drug Class:** Non-opioid analgesic and antipyretic
**Analysis Confidence:** 0.95/1.00

---

## üß¨ Mechanism of Action
Paracetamol selectively inhibits cyclooxygenase (COX-2) more than COX-1 in the central nervous system, reducing prostaglandin synthesis and thereby mediating analgesic and antipyretic effects. It exhibits weak peripheral anti-inflammatory activity compared to NSAIDs. The exact central mechanism may ...

---

## ‚öóÔ∏è Pharmacokinetics Summary
- **Absorption:** Paracetamol is rapidly and nearly completely absorbed from the small intestine after oral administra...
- **Metabolism:** Primarily hepatic metabolism occurs via phase II conjugation: 50-60% to paracetamol-glucuronide, 25-...
- **Elimination:** Elimination is predominantly renal, with 90-100% of dose excreted as metabolites in urine within 24 ...
- **Half-Life:** 1.5-3 hours in healthy adults; 3-8 hours in hepatic impairment; up to 10-15 hours in neonates or severe overdose.

---

## ‚ö†Ô∏è Key Safety Information

### ‚ö†Ô∏è BLACK BOX WARNINGS

1. Severe liver injury may occur with therapeutic doses (>4000 mg/day) or overdose; acute liver failure can lead to transplantation or death.
2. Do not exceed recommended dose; multiple products may contain paracetamol leading to inadvertent overdose.

### Contraindications (3 identified)

- **N/A** (N/A)
- **N/A** (N/A)
- **N/A** (N/A)

---

## üîó Interactions Summary

### üî¥ SEVERE Drug Interactions (1)

- **Alcohol (chronic use)**
  - Effect: Enhanced hepatotoxicity risk even at therapeutic doses....
  - Management: Avoid concurrent use or limit paracetamol to 2 g/day; counsel on abstinence....

### üü° Moderate Drug Interactions (3)

- **Warfarin**: Elevated INR, increased bleeding risk....
- **Probenecid**: Increased paracetamol levels and half-life....
- **Isoniazid**: Potential hepatotoxicity....

### Food Interactions (2)

- **High-fat meals**: No dose adjustment; administer without regard to meals....
- **Alcohol (acute ingestion)**: Separate by >4 hours if possible; avoid in chronic users....

---

## üí° Recommendations

### ‚úÖ What TO DO:

1. **Educate on total intake from all sources (e.g., combination products).**
   - Reduces risk of hepatotoxicity based on pharmacokinetic data and overdose epidemiology....

2. **IV NAC 150 mg/kg over 1 hour, then 50 mg/kg over 4 hours, then 100 mg/kg over 16 hours.**
   - Replenishes glutathione to detoxify NAPQI; Rumack-Matthew nomogram guides need....

3. **AUDIT-C questionnaire; cap at 2000 mg/day if positive.**
   - CYP2E1 induction increases NAPQI; limited evidence supports dose cap....

### ‚ùå What NOT TO DO:

1. **Do not combine multiple paracetamol-containing products without dose calculation.**

2. **Do not use long-term (>14 days) without LFT monitoring.**

3. **Do not administer to patients with G6PD deficiency routinely.**

### üßØ Debunked Claims:

1. **Paracetamol is completely safe with no risk of liver damage at any dose.**
   - Therapeutic misadventure causes 50% of acute liver failure cases....

2. **Paracetamol cures the common cold or flu.**
   - Symptomatic relief only; no antiviral activity....

3. **Daily paracetamol prevents hangovers.**
   - No prophylactic efficacy; increases hepatotoxicity with alcohol....


---

**For complete details including all interactions, dosing adjustments, and comprehensive recommendations, see the detailed report.**

‚ö†Ô∏è **DISCLAIMER:** This analysis is for educational and research purposes only. Always consult qualified healthcare providers for medication decisions.
